Journals / Turkish archives of otorhinolaryngology / 2021 / Cilt: 59 - Sayı: 3

The Importance of Prostate-Specific Membrane Antigen Expression in Carotid Body Paragangliomas

Pages
203–209
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

These data might be a guide for future studies that are planned for either diagnostic or therapeutic approaches to CBPs

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Prostate-specific membrane antigen (PSMA) is a transmembrane protein expressed in prostate cancer.
📊
Key Findings & Data:Immunohistochemical examination results of Ki-67, S100, synaptophysin, chromogranin were retrieved from patient files.
💡
Conclusion & Impact:These data might be a guide for future studies that are planned for either diagnostic or therapeutic approaches to CBPs
🔬Design:Research Article
📍Scope:12 specimens
⚙️Variables:Domain Parameters

Özet

Prostate-specific membrane antigen (PSMA) is a transmembrane protein expressed in prostate cancer. It is, however, also expressed in the neovasculature of some non-prostatic solid tumors. Carotid body paragangliomas (CBPs) are highly vascular neoplasms. In this study, we aimed to investigate the possible role of PSMA expression in CBPs. There are no studies in the literature that report to have investigated the relationship between PSMA and CBPs. Methods: This study is a retrospective analysis of cases diagnosed with CBP based on their demographic, clinical, radiological, surgical and immunohistochemical findings. Immunohistochemical examination results of Ki-67, S100, synaptophysin, chromogranin were retrieved from patient files. Then, the paraffin blocks of CBPs specimens, stained by PSMAantibody by immunohistochemical methods were examined histopathologically. Results: The number of patients operated on for CBP was 12 (four men and eight women). Ten out of 12 specimens were suitable for staining and histopathological examination. Capsular and/ or vascular invasions of tumors were seen in complicated cases. Intratumoral vascular PSMA expression was seen in all specimens except one. Extratumoral vascular PSMA expression was not detected in any of the cases. Tumoral cell PSMA staining was seen in six of ten cases. Conclusion: We found higher intratumoral vascular expressions of PSMA nearly in all CBPs, but we could not assess the statistical significance because of the small number of specimens. These data might be a guide for future studies that are planned for either diagnostic or therapeutic approaches to CBPs

🔖

Cite This Article

YASAN, H., KUMBUL, Y. Ç., CİRİŞ, İ. M., OKUR, E. (2021). The Importance of Prostate-Specific Membrane Antigen Expression in Carotid Body Paragangliomas. Turkish archives of otorhinolaryngology, Cilt: 59 - Sayı: 3, 203–209. https://ajindex.com/articles/403379

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. Scholzen T, Gerdes J. The Ki-67 protein: from the known and the unknown. J Cell Physiol 2000; 182: 311-22. [Crossref] 2. Melachuri S, Valappil B, Snyderman C. Variations in surgical outcomes of carotid body tumors by surgical specialty. Laryngoscope 2021; 131: 190-5. [Crossref] 3. Williams MD. Paragangliomas of the head and neck: an overview from diagnosis to genetics. Head Neck Pathol 2017; 11: 278-87. [Crossref] 4. Haffner MC, Laimer J, Chaux A, Schäfer G, Obrist P, Brunner A, et al. High expression of prostate-specific membrane antigen in the tumor-associated neo-vasculature is associated with worse prognosis in squamous cell carcinoma of the oral cavity. Mod Pathol 2012; 25: 1079-85. [Crossref] 5. Tripathy S, Tripathi M, Dattagupta S, Parida GK, Shamim SA. In vivo PSMA expression in head and neck paragangliomas on 68Ga PSMA 11 PET/CT. Clin Nucl Med 2019; 44: 398-400. [Crossref] 6. Choudhury PS, Gupta M. Theranostics in India: a particularly exquisite concept or an experimental tool. Nucl Med Mol Imaging 2019; 53: 92-5. [Crossref] 7. Fathalla AE, Elalfy MA. Clinical outcome of carotid body paraganglioma management: a review of 10-year experience. J Oncol 2020: 6081273. [Crossref] 8. Rashaideh MA, Neshwati FM, As’ad M, Ajarmeh E, Alsharayeh E, Yasin N, et al. Diagnosis and treatment of carotid body tumors: a retrospective analysis of a single-center experience over 12 years. Indian J Vasc Endovasc Surg 2020; 7: 34-8. [Crossref] 9. Offergeld C, Brase C, Yaremchuk S, Mader I, Rischke HC, Gläsker S, et al. Head and neck paragangliomas: clinical and molecular genetic classification. Clinics (Sao Paulo) 2012; 67: 19- 28. [Crossref] 10. Jianu DC, Jianu SN, Motoc AG, Dan TF, Poenaru M, Tăban S, et al. An evaluation on multidisciplinary management of carotid body paragangliomas: a report of seven cases. Rom J Morphol Embryol 2016; 57: 853-9. [Crossref] 11. Baz RA, Scheau C, Sârbu N, Costea DO, Dijmărescu A, Bordei P. Carotid paragangliomas: case report and imaging review. Folia Morphol (Warsz). 2021; 80: 699-706. [Crossref] 12. Zade A, Trivedi C, Ingule A, Jha S, Agrwal A. Incidentally detected 18F-PSMA uptake in glomus jugulare. Clin Nucl Med 2020; 45: 360-2. [Crossref] 13. Foss CA, Mease RC, Cho SY, Kim HJ, Pomper MG. GCPII imaging and cancer. Curr Med Chem 2012; 19: 1346-59. [Crossref]